Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma

Journal of Surgical Research

Volumn 189, Issue 1, 2014, Pages 81-88

  Chen, Hongwei ^a   Miao, Jinlin ^b   Li, Hongchen ^a   Wang, Chunhua ^a   Li, Junliang ^a   Zhu, Yong ^a   Wang, Jianxin ^a   Wu, Xia ^a   Qiao, Hongying ^a  

^a FIRST HOSPITAL OF QINHUANGDAO   (China)

^b Fourth People's Hospital of Taizhou   (China)

Author keywords

Hepatocellular carcinoma; Ki 67; PAK6; Proliferation

Indexed keywords

KI 67 ANTIGEN; P21 ACTIVATED KINASE 6;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

HEPATOCELLULAR CARCINOMA; KI-67; PAK6; PROLIFERATION;

CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; P21-ACTIVATED KINASES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898804154     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.01.049     Document Type: Article

References (43)

1. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
3. C.J. Chen, M.W. Yu, and Y.F. Liaw Epidemiological characteristics and risk factors of hepatocellular carcinoma J Gastroenterol Hepatol 12 1997 S294
4. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339
5. J. Bruix, L. Boix, M. Sala, and J.M. Llovet Focus on hepatocellular carcinoma Cancer Cell 5 2004 215
6. P. Laurent-Puig, P. Legoix, and O. Bluteau et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 120 2001 1763
7. X.M. Wang, L.Y. Yang, L. Guo, C. Fan, and F. Wu p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection Cancer 115 2009 4554
8. W.Y. Lau, and E.C. Lai Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 2008 237
9. E. Manser, T. Leung, H. Salihuddin, Z.S. Zhao, and L. Lim A brain serine/threonine protein kinase activated by Cdc42 and Rac1 Nature 367 1994 40
10. U.G. Knaus, S. Morris, H.J. Dong, J. Chernoff, and G.M. Bokoch Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors Science 269 1995 221
11. G.A. Martin, G. Bollag, F. McCormick, and A. Abo A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20 EMBO J 14 1995 1970
12. S. Bagrodia, S.J. Taylor, K.A. Jordon, L. Van Aelst, and R.A. Cerione A novel regulator of p21-activated kinases J Biol Chem 273 1998 23633
13. R. Kumar, and R.K. Vadlamudi Emerging functions of p21-activated kinases in human cancer cells J Cell Physiol 193 2002 133
14. G.M. Bokoch Biology of the p21-activated kinases Annu Rev Biochem 72 2003 743
15. C. Hofmann, M. Shepelev, and J. Chernoff The genetics of Pak J Cell Sci 117 2004 4343
16. R. Kumar, A.E. Gururaj, and C.J. Barnes p21-activated kinases in cancer Nat Rev Cancer 6 2006 459
17. C.M. Wells, and G.E. Jones The emerging importance of group II PAKs Biochem J 425 2010 465
18. Z.M. Jaffer, and J. Chernoff p21-activated kinases: three more join the Pak Int J Biochem Cell Biol 34 2002 713
19. Z.S. Zhao, and E. Manser PAK and other Rho-associated kinases-effectors with surprisingly diverse mechanisms of regulation Biochem J 386 2005 201
20. L.E. Arias-Romero, and J. Chernoff A tale of two Paks Biol Cell 100 2008 97
21. J.H. Carter, L.E. Douglass, and J.A. Deddens et al. Pak-1 expression increases with progression of colorectal carcinomas to metastasis Clin Cancer Res 10 2004 3448
22. S. Bekri, J. Adelaide, and S. Merscher et al. Detailed map of a region commonly amplified at 11q13 - >q14 in human breast carcinoma Cytogenet Cell Genet 79 1997 125
23. M.K. Siu, E.S. Wong, and H.Y. Chan et al. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion Int J Cancer 127 2010 21
24. Y.P. Ching, V.Y. Leong, M.F. Lee, H.T. Xu, D.Y. Jin, and I.O. Ng P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation Cancer Res 67 2007 3601
25. R.K. Vadlamudi, L. Adam, and R.A. Wang et al. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells J Biol Chem 275 2000 36238
26. L. Adam, R. Vadlamudi, M. Mandal, J. Chernoff, and R. Kumar Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1 J Biol Chem 275 2000 12041
27. M. Sato, Y. Matsuda, and T. Wakai et al. P21-activated kinase-2 is a critical mediator of transforming growth factor-beta-induced hepatoma cell migration J Gastroenterol Hepatol 28 2013 1047
28. D.W. Parsons, T.L. Wang, and Y. Samuels et al. Colorectal cancer: mutations in a signalling pathway Nature 436 2005 792
29. S. Chen, T. Auletta, and O. Dovirak et al. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification Cancer Biol Ther 7 2008 1793
30. C.M. Wells, A.D. Whale, M. Parsons, J.R. Masters, and G.E. Jones PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion J Cell Sci 123 2010 1663
31. H.J. Zhang, M.K. Siu, and M.C. Yeung et al. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma Carcinogenesis 32 2011 765
32. W. Gong, Z. An, and Y. Wang et al. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration Int J Cancer 125 2009 548
33. Z.P. Fang, B.G. Jiang, X.F. Gu, B. Zhao, R.L. Ge, and F.B. Zhang P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma Acta Pharmacol Sin 35 2014 82
34. S.R. Lee, S.M. Ramos, and A. Ko et al. AR and ER interaction with a p21-activated kinase (PAK6) Mol Endocrinol 16 2002 85
35. F. Yang, X. Li, M. Sharma, M. Zarnegar, B. Lim, and Z. Sun Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6 J Biol Chem 276 2001 15345
36. R. Kaur, X. Yuan, M.L. Lu, and S.P. Balk Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins Prostate 68 2008 1510
37. X. Wen, X. Li, and B. Liao et al. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel Urology 73 2009 1407
38. E.J. Lee, M. McClelland, Y. Wang, F. Long, S.H. Choi, and J.H. Lee Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix Oncol Res 18 2010 401
39. U. Woelfle, J. Cloos, and G. Sauter et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer Cancer Res 63 2003 5679
40. A.S. Befeler, and A.M. Di Bisceglie Hepatocellular carcinoma: diagnosis and treatment Gastroenterology 122 2002 1609
41. M. Kitamoto, T. Nakanishi, and S. Kira et al. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis Cancer 72 1993 1859
42. C.D. Mann, C.P. Neal, G. Garcea, M.M. Manson, A.R. Dennison, and D.B. Berry Prognostic molecular markers in hepatocellular carcinoma: a systematic review Eur J Cancer 43 2007 979
43. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674